Amydis, Inc.
PrivateLast Round
Grant
Mar 11, 2026
Total Funding Raised
$21.53M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Amydis, Inc. is a biotechnology company developing proprietary ocular tracers that enable the identification of molecular biomarkers for diseases of the eye, heart, and brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Imaging, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amydis, Inc. Comparables
Compare Amydis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RetiSpec | 77% | |
| NeuroVision Imaging | 76% | |
| Cognoptix | 76% | |
Amydis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2026 | ||||
| Grant | Nov 14, 2023 | ||||
| Series A Extension | Dec 29, 2022 | ||||
| Grant | Oct 27, 2022 | ||||
| Series A | Apr 22, 2022 | ||||
Grant | Sep 2, 2021 |
Key People
Founding team and executive leadership
Amydis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Series A Extension |
| NIH RADx | Grant, Series A Extension |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Series A Extension |
| National Institute of Neurological Disorders and Stroke | Series A Extension |
| National Institutes of Health (NIH) | Grant |
| Stead Impact Ventures and Foundation | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 170% MoM, reaching 2.3K.
- Mar 11, 2026
$3M grant round led by National Institute on Aging.
Amydis, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amydis, Inc.'s valuation, stock price, and market status.